1 year return (CAGR)
92.02%
Kymera Therapeutics Inc Exchange (NASDAQ, USD)
KYMR
109.30
+0.95 (+0.88%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
91.72%
5 year return (CAGR)
13.22%
10 year return (CAGR)
-
Adobe 2026 Q3 – Is sentiment driving the price?
Read MoreMarketcap
8.99B
Price/Sales
85.64
Ent value
9.01B
Price/Book
5.97
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
7.02%
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 106.52 |
| Daily high | 110.04 |
| Daily low | 104.19 |
| Daily Volume | 1.03M |
| All-time high | 127.31 |
| 1y analyst estimate | 138.64 |
| Beta | 1.97 |
| EPS (TTM) | -3.05 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | 19 Feb 2026 |
Downside potential
Loading...
Downside potential data
| KYMR | S&P500 | |
| Current price drop from All-time high | -14.15% | -0.66% |
| Highest price drop | -87.51% | -56.47% |
| Date of highest drop | 27 Oct 2023 | 9 Mar 2009 |
| Avg drop from high | -47.05% | -10.67% |
| Avg time to new high | 39 days | 12 days |
| Max time to new high | 1242 days | 1805 days |
News
